Tilia Fiduciary Partners, Inc. Novartis Ag Transaction History

Tilia Fiduciary Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $15,110 - $18,504	-200 Reduced 18.71%	869 $78,000
Q3 2022 Oct 26, 2022	SELL	$74.61 - $87.26 $1,865 - $2,181	-25 Reduced 2.29%	1,069 $81,000
Q2 2022 Aug 01, 2022	BUY	$80.52 - $93.75 $18,117 - $21,093	225 Added 25.89%	1,094 $92,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $69,259 - $76,584	869 New	869 $76,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Tilia Fiduciary Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Tilia Fiduciary Partners, Inc. with notifications on news.